COMMUNIQUÉS West-GlobeNewswire

Teleflex Announces Tenth Anniversary of GuideLiner® Catheter Product Line
25/09/2019
Company Celebrates 10 Years of the Industry's Leading Guide Extension Catheter with More Than 1 Million Units Sold Worldwide WAYNE, Pa., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading [...]
Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion
25/09/2019
Press release Malmö, 25 September 2019 Acarix carries out a rights issue of approximately SEK 51.8 million to finance an increased market expansion The board of directors of Acarix AB ("Acarix" or the "Company") has [...]
Chi-Med Highlights Presentation of Clinical Data from the Successful SANET-ep Phase III Trial at ESMO Annual Meeting
25/09/2019
– Late-Breaking Abstract of the positive SANET-ep Phase III trial of surufatinib in patients with non-pancreatic neuroendocrine tumors (“NET”) to be presented – – Conference call and webcast with lead trial [...]
Sequana Medical Announces 2019 Half Year Results and Year-to-date Business Update
25/09/2019
Continued strong progress since IPO in February 2019: Commenced POSEIDON pivotal study to support approval of the alfa pump® in the U.S. & Canada Achieved clinical proof-of-concept of Direct Sodium Removal (DSR), [...]
Sequana Medical Announces First Patient Enrolled in North American alfapump® Pivotal Study (POSEIDON)
25/09/2019
Study aims to support the approval of the alfa pump in U.S. and Canada Results anticipated by mid-2021 U.S. launch of the alfa pump planned for H1 2022 GHENT, Belgium, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Sequana Medical [...]
ADDEX THERAPEUTICS TO RELEASE HALF-YEAR 2019 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON SEPTEMBER 30, 2019
25/09/2019
Geneva, Switzerland, September 25, 2019 – Addex Therapeutics (SIX:ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, will discuss its half-year 2019 financial results, [...]
Align Technology Further Advances Digital Dentistry in China With the Launch of the iTero Element 2 Scanner
25/09/2019
Receives approval from China ’s National Medical Products Administration to manufacture and sell the iTero Element 2 Scanner in China Provides localized technology and manufacturing capabilities to better serve China [...]
‘Better together’: Mental Health Commission of Canada and Canadian Mental Health Association announce strengthened collaboration
25/09/2019
From Mental Health Commission of Canada TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- At the Canadian Mental Health Association’s (CMHA) national Mental Health For All conference in Toronto today, CMHA and the Mental [...]
« Mieux ensemble » : Renforcement de la collaboration entre la Commission de la santé mentale du Canada et l’Association canadienne pour la santé mentale
25/09/2019
De la Commission de la santé mentale du Canada TORONTO, 24 sept. 2019 (GLOBE NEWSWIRE) -- Lors de son Congrès annuel La santé mentale pour tous aujourd’hui à Toronto, l’Association canadienne pour la santé mentale (ACSM [...]
Bone Bank Allografts Launches Global Sales Force Initiative
24/09/2019
Distributor Expansion to Support Growing Demand for Orthobiologics SAN ANTONIO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Bone Bank Allografts (BBA), a leading provider of regenerative medicine technologies to the surgical [...]
Rockwell Medical, Inc. to Present at 2019 Cantor Global Healthcare Conference
24/09/2019
WIXOM, Mich., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, is scheduled to present at the 2019 [...]
BioCryst Pharmaceuticals to Present at Cantor Global Healthcare Conference
24/09/2019
RESEARCH TRIANGLE PARK, N.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the company will present at the Cantor Global Healthcare Conference in New York on [...]
Opiant Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
24/09/2019
SANTA MONICA, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today [...]
SeaSpine® Announces Exclusive Development and Licensing Agreement with restor3D®
24/09/2019
CARLSBAD, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
Menlo Therapeutics Announces Completion of Enrollment of 233 Patients in Phase 2 Trial of Serlopitant in Patients with Chronic Pruritus of Unknown Origin
24/09/2019
- Results expected in Q1 2020 - REDWOOD CITY, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced that it has completed patient [...]
Colibri Heart Valve Receives a United States Patent Directed to a Replacement Heart Valve that Includes a Dry Valve Sutured to a Stent Member
24/09/2019
BROOMFIELD, CO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that U.S. Patent No. 10,390,945 (“the ‘945 Patent”) was issued on August 27 [...]
PhaseBio Announces Completion of Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor
24/09/2019
Preliminary Results from Supratherapeutic-Dose Ticagrelor Cohort Are Consistent with Earlier Phase 2a Cohorts and Previously Published Phase 1 Trial MALVERN, Pa. and SAN DIEGO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- [...]
Galapagos initiates Phase 1 trial for second Toledo compound
24/09/2019
Second generation compound of novel target class with dual action in inflammatory disorders Discovered and validated on Galapagos’ target discovery platform Mechelen, Belgium; 24 September 2019, 22.01 CET – Galapagos NV [...]
Aeterna Zentaris Announces Closing of Approximately $5.0 Million Registered Direct Offering
24/09/2019
CHARLESTON, S.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), a specialty biopharmaceutical company engaged in commercializing novel pharmaceutical therapies, principally through [...]

Pages